Cash flow Evotec SE CBOE

Stocks

0IRF

DE0005664809

Biotechnology & Medical Research

Market Closed - CBOE 09:00:00 11/09/2026 pm IST			5-day change	1st Jan Change
3.217 ^EUR	0.00%		0.00%	-40.37%

09/09	Evotec Initiates Phase 1 Trial of Potential Smallpox, Mpox Treatment	MT
09/09	Evotec Commences Early-stage Study of Potential Orthopoxvirus Therapy	MT

bd595964aa5c3a51b.kOa0bjFjRSFMakQnCbrsHcGYftiuVkXfEYfnTDL0HTI.99bMOUMBcxMaOD5NSumaavXNS7mbNy_nRumtH3S4VlXTlcMpaykiGRMbdA

Published financial data: EVOTEC SE

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Revenues	62Cr	75Cr	78Cr	80Cr	79Cr
Total Revenues	62Cr	75Cr	78Cr	80Cr	79Cr
Cost of Goods Sold, Total	47Cr	58Cr	61Cr	68Cr	67Cr
Gross Profit	15Cr	17Cr	18Cr	11Cr	11Cr
Selling General & Admin Expenses, Total	11Cr	16Cr	17Cr	19Cr	18Cr
R&D Expenses	7.22Cr	7.66Cr	6.85Cr	5.09Cr	3.75Cr
Other Operating Expenses	-6.53Cr	-7.91Cr	-6.41Cr	-4.53Cr	-3.32Cr
Other Operating Expenses, Total	11Cr	15Cr	17Cr	19Cr	18Cr
Operating Income	3.92Cr	2.03Cr	10.03L	-7.89Cr	-6.6Cr
Interest Expense, Total	-92.54L	-1.32Cr	-1.17Cr	-1.17Cr	-
Interest And Investment Income	22.96L	83.36L	92.63L	24.35L	44.24L
Net Interest Expenses	-69.58L	-48.14L	-24.76L	-92.64L	44.24L
Income (Loss) On Equity Invest.	-1.66Cr	-1.6Cr	-2.08Cr	-43.12L	-10.85L
Currency Exchange Gains (Loss)	78.43L	1.31Cr	-25L	44L	1.76Cr
Other Non Operating Income (Expenses)	-61T	-7L	17.86L	-37.64L	-5.15Cr
EBT, Excl. Unusual Items	2.35Cr	1.19Cr	-2.29Cr	-9.19Cr	-9.66Cr
Restructuring Charges	-	-	-	-5.49Cr	-6L
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	21Cr	-17Cr	-91.43L	-3.85Cr	1.21Cr
Gain (Loss) On Sale Of Assets	-1L	-2L	-	-	-
Asset Writedown	-7L	-	-50.11L	-	-
Other Unusual Items	26L	56.08L	-4.35Cr	-86.74L	-16.8L
EBT, Incl. Unusual Items	24Cr	-15Cr	-8.06Cr	-19Cr	-8.68Cr
Income Tax Expense	2.15Cr	2.17Cr	33.2L	21.02L	1.68Cr
Earnings From Continuing Operations	22Cr	-18Cr	-8.39Cr	-20Cr	-10Cr
Net Income to Company	22Cr	-18Cr	-8.39Cr	-20Cr	-10Cr
Minority Interest	-	-	-	-	-
Net Income - (IS)	22Cr	-18Cr	-8.39Cr	-20Cr	-10Cr
Net Income to Common Incl Extra Items	22Cr	-18Cr	-8.39Cr	-20Cr	-10Cr
Net Income to Common Excl. Extra Items	22Cr	-18Cr	-8.39Cr	-20Cr	-10Cr
Per Share Items
Net EPS - Basic	1.3	-0.99	-0.47	-1.11	-0.58
Basic EPS - Continuing Operations	1.3	-0.99	-0.47	-1.11	-0.58
Basic Weighted Average Shares Outstanding	17Cr	18Cr	18Cr	18Cr	18Cr
Net EPS - Diluted	1.3	-0.99	-0.47	-1.11	-0.58
Diluted EPS - Continuing Operations	1.3	-0.99	-0.47	-1.11	-0.58
Diluted Weighted Average Shares Outstanding	17Cr	18Cr	18Cr	18Cr	18Cr
Normalized Basic EPS	0.09	0.04	-0.08	-0.32	-0.34
Normalized Diluted EPS	0.09	0.04	-0.08	-0.32	-0.34
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	8.93Cr	8.18Cr	7.21Cr	7L	87.43L
EBITA	4.96Cr	2.78Cr	71.27L	-7.3Cr	-6.16Cr
EBIT	3.92Cr	2.03Cr	10.03L	-7.89Cr	-6.6Cr
EBITDAR	9.02Cr	8.23Cr	7.24Cr	10L	99.22L
Effective Tax Rate - (Ratio)	9.06	-14.09	-4.12	-1.08	-19.31
Total Current Taxes	1.64Cr	1.4Cr	79.17L	74.33L	20.58L
Total Deferred Taxes	50.66L	77.22L	-45.97L	-53.31L	1.47Cr
Normalized Net Income	1.47Cr	74.41L	-1.43Cr	-5.74Cr	-6.04Cr
Interest Capitalized	-	-	-	26.24L	16.37L
Interest on Long-Term Debt	37.28L	38.41L	58.32L	47.27L	46.23L
Non-Cash Pension Expense	98T	1L	-4L	-13.87L	4L
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	7.35Cr	7.77Cr	7.39Cr	5.05Cr	3.79Cr
Net Rental Expense, Total	9L	5L	3L	3L	11.79L
Imputed Operating Lease Interest Expense	1L	1L	49.41T	73.12T	34.8T
Imputed Operating Lease Depreciation	8L	4L	2L	3L	11.44L
Stock-Based Comp., Other (Total)	78.05L	99.19L	96.3L	50.35L	37.78L
Total Stock-Based Compensation	78.05L	99.19L	96.3L	50.35L	37.78L

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Assets
Cash And Equivalents	70Cr	42Cr	51Cr	31Cr	42Cr
Short Term Investments	16Cr	30Cr	9.32Cr	9.04Cr	5.79Cr
Total Cash And Short Term Investments	86Cr	72Cr	60Cr	40Cr	48Cr
Accounts Receivable, Total	15Cr	20Cr	12Cr	16Cr	16Cr
Other Receivables	2.34Cr	5.44Cr	8.07Cr	4.19Cr	3.85Cr
Total Receivables	18Cr	26Cr	20Cr	20Cr	20Cr
Inventory	2.58Cr	2.98Cr	3.09Cr	3.11Cr	2.93Cr
Prepaid Expenses	1.92Cr	1.69Cr	1.84Cr	2.22Cr	1.9Cr
Other Current Assets, Total	2.09Cr	5.17Cr	4.57Cr	2.76Cr	3.56Cr
Total Current Assets	110.09Cr	107.37Cr	90Cr	68Cr	76Cr
Gross Property Plant And Equipment	69Cr	92Cr	115.69Cr	130.16Cr	107.42Cr
Accumulated Depreciation	-20Cr	-27Cr	-35Cr	-48Cr	-52Cr
Net Property Plant And Equipment	48Cr	65Cr	81Cr	82Cr	55Cr
Long-term Investments	28Cr	15Cr	14Cr	4.22Cr	5.26Cr
Goodwill	26Cr	27Cr	28Cr	28Cr	27Cr
Other Intangibles, Total	3.09Cr	2.38Cr	1.55Cr	2.64Cr	3.16Cr
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	1.74Cr	1.03Cr	1.43Cr	1.73Cr	29.49L
Other Long-Term Assets, Total	6.2Cr	7.73Cr	9.52Cr	3.78Cr	3.69Cr
Total Assets	223.52Cr	225.72Cr	225.25Cr	191.25Cr	171.39Cr
Liabilities
Accounts Payable, Total	7.26Cr	9.73Cr	13Cr	8.58Cr	6.48Cr
Accrued Expenses, Total	3.55Cr	4.92Cr	5.09Cr	4.63Cr	5.11Cr
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	3.61Cr	15.56L	13Cr	2.71Cr	8.15Cr
Current Portion of Leases	1.45Cr	1.48Cr	1.91Cr	1.96Cr	2.22Cr
Current Income Taxes Payable	1.06Cr	89.87L	55.65L	85.17L	1.06Cr
Unearned Revenue Current, Total	13Cr	14Cr	11Cr	11Cr	11Cr
Other Current Liabilities	2.85Cr	2.92Cr	1.69Cr	4.74Cr	2.99Cr
Total Current Liabilities	32Cr	34Cr	46Cr	34Cr	37Cr
Long-Term Debt	33Cr	33Cr	31Cr	26Cr	19Cr
Long-Term Leases	14Cr	16Cr	17Cr	13Cr	15Cr
Unearned Revenue Non Current	3.45Cr	21Cr	16Cr	19Cr	15Cr
Pension & Other Post Retirement Benefits	1.3Cr	1.25Cr	1.2Cr	1.02Cr	1.03Cr
Deferred Tax Liability Non Current	1.77Cr	1.85Cr	1.81Cr	1.45Cr	1.47Cr
Other Non Current Liabilities	55.38L	48.73L	54.65L	1.07Cr	94.38L
Total Liabilities	86Cr	107.01Cr	113.26Cr	96Cr	90Cr
Common Stock, Total	18Cr	18Cr	18Cr	18Cr	18Cr
Additional Paid In Capital	143.01Cr	144Cr	144.97Cr	145.47Cr	145.85Cr
Retained Earnings	-22Cr	-39Cr	-48Cr	-67Cr	-78Cr
Treasury Stock	-	-	-	-	-15.48L
Comprehensive Income and Other	-1.26Cr	-3.74Cr	-3.06Cr	-73.46L	-4.51Cr
Total Common Equity	137.77Cr	118.72Cr	111.99Cr	95Cr	81Cr
Minority Interest	-	-	-	-	-
Total Equity	137.77Cr	118.72Cr	111.99Cr	95Cr	81Cr
Total Liabilities And Equity	223.52Cr	225.72Cr	225.25Cr	191.25Cr	171.39Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	18Cr	18Cr	18Cr	18Cr	18Cr
ECS Total Common Shares Outstanding	18Cr	18Cr	18Cr	18Cr	18Cr
Book Value / Share	7.81	6.72	6.33	5.37	4.58
Tangible Book Value	108.93Cr	89Cr	83Cr	64Cr	51Cr
Tangible Book Value Per Share	6.18	5.03	4.68	3.63	2.87
Total Debt	51Cr	51Cr	63Cr	44Cr	45Cr
Net Debt	-35Cr	-21Cr	2.21Cr	4.26Cr	-2.87Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-	1.49Cr	1.22Cr	1.22Cr
Debt Equivalent Oper. Leases	71.6L	42.08L	23.84L	27.2L	94.32L
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Equity Method Investments, Total	1.31Cr	1.6Cr	30.71L	21.38L	46.29L
Account Code - Inventory Valuation	8	8	8	6	6
Inventories - Raw Materials, Total	2.5Cr	2.79Cr	2.59Cr	2.95Cr	2.7Cr
Inventories - Work In Process, Total	8L	19.08L	49.89L	16.67L	23.33L
Buildings, Total	20Cr	24Cr	27Cr	32Cr	31Cr
Machinery, Total	26Cr	34Cr	40Cr	50Cr	48Cr
Full Time Employees	4.2T	4.95T	5.06T	4.74T	4.47T
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	21L	28.33L	-	-	-
Order Backlog	-	-	-	-	-

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Net Income	22Cr	-18Cr	-8.39Cr	-20Cr	-10Cr
Depreciation & Amortization - CF	5.56Cr	7.27Cr	8.6Cr	9.51Cr	9Cr
Amortization of Goodwill and Intangible Assets - (CF)	1.03Cr	74.23L	61.24L	59.66L	44.54L
Depreciation & Amortization, Total	6.59Cr	8.01Cr	9.22Cr	10Cr	9.45Cr
Amortization of Deferred Charges, Total - (CF)	16.8L	15.59L	8L	5L	50.24L
(Gain) Loss From Sale Of Asset	1L	2L	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-22Cr	17Cr	91.43L	4.82Cr	-83.75L
Asset Writedown & Restructuring Costs	7L	-	50.11L	1.22Cr	8L
(Income) Loss On Equity Investments - (CF)	2.84Cr	1.51Cr	2.08Cr	43.12L	10.85L
Stock-Based Compensation (CF)	78.05L	99.19L	96.3L	50.35L	37.78L
Other Operating Activities, Total	2.8Cr	-1.95Cr	-72.19L	11Cr	5.84Cr
Change In Accounts Receivable	-4.8Cr	-3.84Cr	-	-	-2.87Cr
Change In Inventories	-1.17Cr	-44.1L	-	-	-95.62L
Change In Accounts Payable	3.13Cr	2.45Cr	-	-	-73.04L
Change in Unearned Revenues	6.31Cr	18Cr	-	-	-
Change In Income Taxes	1.88Cr	2.94Cr	-	-	-
Change in Other Net Operating Assets	-5.59Cr	-7.36Cr	-99.44L	-6.82Cr	-1.52Cr
Cash from Operations	12Cr	20Cr	3.64Cr	1.82Cr	-91.79L
Capital Expenditure	-12Cr	-18Cr	-21Cr	-12Cr	-7.25Cr
Sale of Property, Plant, and Equipment	-	-	5L	20L	2L
Cash Acquisitions	-4L	-2.09Cr	20.88L	-	-
Sale (Purchase) of Intangible assets	-	-	-26.77L	-1.48Cr	-1.01Cr
Investment in Marketable and Equity Securities, Total	-12Cr	-21Cr	19Cr	4.91Cr	25Cr
Net (Increase) Decrease in Loans Originated / Sold - Investing	-73.76L	-41.27L	-	-	-
Other Investing Activities, Total	-	-	1.04Cr	99.87L	51.68L
Cash from Investing	-24Cr	-42Cr	-1.33Cr	-7.12Cr	17Cr
Long-Term Debt Issued, Total	3.08Cr	-	22Cr	9L	4.4Cr
Total Debt Issued	3.08Cr	-	22Cr	9L	4.4Cr
Long-Term Debt Repaid, Total	-3.67Cr	-5.31Cr	-14Cr	-15Cr	-7.34Cr
Total Debt Repaid	-3.67Cr	-5.31Cr	-14Cr	-15Cr	-7.34Cr
Issuance of Common Stock	40Cr	7L	2L	4L	2L
Repurchase of Common Stock	-	-	-	-	-15.48L
Other Financing Activities, Total	-	-	-1.29Cr	-97.16L	-68.89L
Cash from Financing	40Cr	-5.24Cr	7.2Cr	-16Cr	-3.76Cr
Foreign Exchange Rate Adjustments	-66T	-1.9Cr	6L	98.66L	-1.27Cr
Miscellaneous Cash Flow Adjustments	-	-	-1T	-	-
Net Change in Cash	28Cr	-28Cr	9.58Cr	-20Cr	11Cr
Supplemental Items
Cash Interest Paid	54.29L	97.98L	1.29Cr	59.2L	54.25L
Cash Income Tax Paid (Refund)	-60.28L	1.85Cr	1.29Cr	-7.61Cr	-1.48Cr
Levered Free Cash Flow	48.66L	-15Cr	-6.98Cr	-8.59Cr	-5.55Cr
Unlevered Free Cash Flow	1.07Cr	-14Cr	-6.25Cr	-7.86Cr	-5.55Cr
Change In Net Working Capital	-2.97Cr	6.51Cr	-5.03Cr	36.93L	3.49Cr
Net Debt Issued / Repaid	-58.92L	-5.31Cr	8.46Cr	-15Cr	-2.94Cr

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Profitability
Return on Assets	1.33	0.57	0.03	-2.37	-2.28
Return on Total Capital	1.58	0.71	0.04	-3.14	-3.11
Return On Equity %	20.5	-13.7	-7.27	-18.92	-11.72
Return on Common Equity	20.5	-13.7	-7.27	-18.92	-11.72
Margin Analysis
Gross Profit Margin %	24.52	23.16	22.4	14.41	14.49
SG&A Margin	17.06	20.79	21.71	23.61	22.32
EBITDA Margin %	14.45	10.88	9.22	0.08	1.11
EBITA Margin %	8.02	3.69	0.91	-9.15	-7.81
EBIT Margin %	6.35	2.71	0.13	-9.9	-8.38
Income From Continuing Operations Margin %	34.87	-23.38	-10.74	-24.6	-13.13
Net Income Margin %	34.87	-23.38	-10.74	-24.6	-13.13
Net Avail. For Common Margin %	34.87	-23.38	-10.74	-24.6	-13.13
Normalized Net Income Margin	2.37	0.99	-1.83	-7.2	-7.66
Levered Free Cash Flow Margin	0.79	-20.01	-8.93	-10.78	-7.05
Unlevered Free Cash Flow Margin	1.72	-18.91	-7.99	-9.86	-7.05
Asset Turnover
Asset Turnover	0.33	0.33	0.35	0.38	0.43
Fixed Assets Turnover	1.5	1.32	1.07	0.98	1.14
Receivables Turnover (Average Receivables)	4.87	4.23	4.8	5.58	4.83
Inventory Turnover (Average Inventory)	23.69	20.76	19.97	22	22.31
Short Term Liquidity
Current Ratio	3.39	3.18	1.94	1.98	2.07
Quick Ratio	3.19	2.89	1.74	1.74	1.85
Operating Cash Flow to Current Liabilities	0.38	0.6	0.08	0.05	-0.02
Days Sales Outstanding (Average Receivables)	74.96	86.37	76.07	65.61	75.61
Days Outstanding Inventory (Average Inventory)	15.41	17.58	18.27	16.64	16.36
Average Days Payable Outstanding	43.9	53.32	69.58	59.03	40.87
Cash Conversion Cycle (Average Days)	46.46	50.63	24.76	23.22	51.1
Long Term Solvency
Total Debt/Equity	37.23	42.68	55.92	46.13	55.02
Total Debt / Total Capital	27.13	29.91	35.86	31.57	35.49
LT Debt/Equity	33.56	41.3	42.6	41.23	42.28
Long-Term Debt / Total Capital	24.45	28.95	27.32	28.22	27.27
Total Liabilities / Total Assets	38.36	47.41	50.28	50.19	52.52
EBIT / Interest Expense	4.24	1.55	0.09	-6.75	-
EBITDA / Interest Expense	11.36	7.64	7.94	1.9	-
(EBITDA - Capex) / Interest Expense	-1.49	-6.15	-10.24	-8.14	-
Total Debt / EBITDA	4.88	5.05	6.72	19.81	15.75
Net Debt / EBITDA	-3.28	-2.11	0.24	1.92	-1.01
Total Debt / (EBITDA - Capex)	-37.2	-6.26	-5.21	-4.61	-10.15
Net Debt / (EBITDA - Capex)	25.04	2.62	-0.18	-0.45	0.65
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	23.38	21.59	3.99	1.99	-1.08
Gross Profit, 1 Yr. Growth %	20.52	14.86	0.57	-34.37	-0.57
EBITDA, 1 Yr. Growth %	0.53	-8.46	-14.01	-99.1	1.24T
EBITA, 1 Yr. Growth %	-21.05	-44	-75.71	-1.12T	-15.6
EBIT, 1 Yr. Growth %	-22.55	-48.18	-95.19	-7.97T	-16.33
Earnings From Cont. Operations, 1 Yr. Growth %	3.33T	-181.51	-52.23	133.67	-47.21
Net Income, 1 Yr. Growth %	3.33T	-181.51	-52.23	133.67	-47.21
Normalized Net Income, 1 Yr. Growth %	-11.3	-49.29	-272.55	300.45	-25.92
Diluted EPS Before Extra, 1 Yr. Growth %	3.14T	-176.77	-52.29	134.03	-47.48
Accounts Receivable, 1 Yr. Growth %	52.57	31.94	-39.01	31.57	1.17
Inventory, 1 Yr. Growth %	89.86	15.63	3.57	0.75	-5.8
Net Property, Plant and Equip., 1 Yr. Growth %	43.67	34.17	24.05	2.15	-32.69
Total Assets, 1 Yr. Growth %	52.85	0.99	-0.21	-15.09	-10.38
Tangible Book Value, 1 Yr. Growth %	187.37	-18.43	-6.72	-22.39	-20.75
Common Equity, 1 Yr. Growth %	90.17	-13.83	-5.67	-14.95	-14.57
Cash From Operations, 1 Yr. Growth %	173.33	66.16	-82.3	-50	-150.38
Capital Expenditures, 1 Yr. Growth %	20.06	52.47	17.63	-44.93	-38.25
Levered Free Cash Flow, 1 Yr. Growth %	-126.24	-3.19T	-52.99	23.08	-29.34
Unlevered Free Cash Flow, 1 Yr. Growth %	-180.35	-1.43T	-55.46	25.83	-29.34
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	17.66	22.48	12.44	2.98	0.44
Gross Profit, 2 Yr. CAGR %	6.79	17.66	7.48	-18.76	-19.22
EBITDA, 2 Yr. CAGR %	-9.41	-5.66	-10.17	-92.09	-61.46
EBITA, 2 Yr. CAGR %	-24.58	-35.05	-62.08	87.05	50.51
EBIT, 2 Yr. CAGR %	-27.57	-37.39	-84.01	94.55	39.09
Earnings From Cont. Operations, 2 Yr. CAGR %	140.33	428.96	-37.6	5.65	11.07
Net Income, 2 Yr. CAGR %	137.66	428.96	-37.6	5.65	11.07
Normalized Net Income, 2 Yr. CAGR %	-42.09	-34.41	-1.16	162.87	19.87
Diluted EPS Before Extra, 2 Yr. CAGR %	127.6	398.56	-39.48	5.66	10.86
Accounts Receivable, 2 Yr. CAGR %	27	41.88	-10.29	-10.42	15.38
Inventory, 2 Yr. CAGR %	54.91	48.17	9.44	2.15	-2.58
Net Property, Plant and Equip., 2 Yr. CAGR %	42.69	38.84	29.01	12.57	-17.08
Total Assets, 2 Yr. CAGR %	37.58	24.24	0.39	-7.95	-12.77
Tangible Book Value, 2 Yr. CAGR %	225.38	53.11	-12.77	-14.92	-21.57
Common Equity, 2 Yr. CAGR %	69.94	28.01	-9.84	-10.43	-14.76
Cash From Operations, 2 Yr. CAGR %	70.16	113.11	-45.4	-70.25	-49.81
Capital Expenditures, 2 Yr. CAGR %	94.87	35.3	33.92	-19.52	-41.69
Levered Free Cash Flow, 2 Yr. CAGR %	-61.18	190.69	278.73	-21.74	-18.89
Unlevered Free Cash Flow, 2 Yr. CAGR %	-46.32	237.18	142.19	-25.14	-18.89
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	18.08	18.95	15.98	8.85	1.61
Gross Profit, 3 Yr. CAGR %	10.6	9.41	11.66	-8.82	-13.1
EBITDA, 3 Yr. CAGR %	-1.7	-9.09	-7.77	-80.61	-56.2
EBITA, 3 Yr. CAGR %	-13.09	-31.7	-52.33	13.76	43.47
EBIT, 3 Yr. CAGR %	-15.16	-35.22	-73.16	26.24	46.85
Earnings From Cont. Operations, 3 Yr. CAGR %	36.87	67.6	137.32	-3.1	-16.16
Net Income, 3 Yr. CAGR %	36.8	66.35	137.32	-3.1	-16.16
Normalized Net Income, 3 Yr. CAGR %	-26.48	-44.6	-6.07	57.57	93.68
Diluted EPS Before Extra, 3 Yr. CAGR %	32.24	58.43	128.03	-5.01	-16.3
Accounts Receivable, 3 Yr. CAGR %	36.01	28.63	7.08	1.92	-6.71
Inventory, 3 Yr. CAGR %	65.79	40.52	31.5	6.46	-0.57
Net Property, Plant and Equip., 3 Yr. CAGR %	75.72	39.79	33.72	19.35	-5.16
Total Assets, 3 Yr. CAGR %	42.53	24.1	15.49	-5.06	-8.77
Tangible Book Value, 3 Yr. CAGR %	139.78	105.17	29.79	-16.1	-16.91
Common Equity, 3 Yr. CAGR %	48.11	35.52	15.63	-11.57	-11.83
Cash From Operations, 3 Yr. CAGR %	-7.86	68.82	-6.6	-46.98	-64.54
Capital Expenditures, 3 Yr. CAGR %	62.21	79.57	29.13	-0.42	-26.32
Levered Free Cash Flow, 3 Yr. CAGR %	-63.07	66.97	57.72	160.38	-26.57
Unlevered Free Cash Flow, 3 Yr. CAGR %	-52.31	56.67	70.96	94.7	-26.57
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	30.31	23.29	15.79	12.29	9.49
Gross Profit, 5 Yr. CAGR %	20.95	16.3	9.34	-2.87	-1.9
EBITDA, 5 Yr. CAGR %	20.48	7.82	-5.18	-64.08	-37.53
EBITA, 5 Yr. CAGR %	14.35	-8.26	-37.63	-3.49	-1.31
EBIT, 5 Yr. CAGR %	10.02	-11.09	-56.48	1.09	4.95
Earnings From Cont. Operations, 5 Yr. CAGR %	51.68	49.89	-0.03	39.35	75.16
Net Income, 5 Yr. CAGR %	50.91	49.56	-0.06	38.73	75.16
Normalized Net Income, 5 Yr. CAGR %	-3.03	-14.74	-17.24	5.58	28.4
Diluted EPS Before Extra, 5 Yr. CAGR %	45.3	44.1	-3.27	34.73	70.89
Accounts Receivable, 5 Yr. CAGR %	40.21	28.96	15.15	11.3	10.32
Inventory, 5 Yr. CAGR %	43.06	39.89	40.41	23.69	16.63
Net Property, Plant and Equip., 5 Yr. CAGR %	62.46	54.1	55.29	28.19	10.46
Total Assets, 5 Yr. CAGR %	44.56	27.63	23.89	10.12	3.23
Tangible Book Value, 5 Yr. CAGR %	63.27	102.97	60.01	44.28	6.1
Common Equity, 5 Yr. CAGR %	45.26	29.11	21.44	14.83	2.35
Cash From Operations, 5 Yr. CAGR %	12.66	79.74	-25.26	-15.47	-27.15
Capital Expenditures, 5 Yr. CAGR %	64.6	60.12	50.24	30.26	-6.04
Levered Free Cash Flow, 5 Yr. CAGR %	-24.77	88.01	-6.29	21.61	25.57
Unlevered Free Cash Flow, 5 Yr. CAGR %	-12.81	81.64	-8.65	16.29	34.75